ArticleScience translational medicine2021

A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models.

Eric S Lightcap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.